Physician profile
Prashant Sharma
NPI 1003547621
$708.36
in general payments reported to CMS, 2019-2025
16 companies · $708 in 2025
The $708 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $155.04 | 2025 | Spravato |
| Exact Sciences Corporation | $79.97 | 2025 | Cologuard Collection Kit |
| Corium, LLC | $62.76 | 2025 | Azstarys |
| Novo Nordisk INC | $56.25 | 2025 | Rybelsus, Ozempic, Wegovy |
| Corcept Therapeutics | $54.98 | 2025 | Korlym |
| Neurocrine Biosciences, INC. | $54.06 | 2025 | |
| Axsome Therapeutics, INC. | $34.50 | 2025 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $32.64 | 2025 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $29.16 | 2025 | Abilify Maintena |
| Vertex Pharmaceuticals Incorporated | $27.11 | 2025 | |
| Indivior INC. | $25.26 | 2025 | Sublocade |
| Abbvie INC. | $24.13 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.33 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.49 | 2025 | Caplyta |
| Lilly USA, LLC | $18.12 | 2025 | Mounjaro |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13.56 | 2025 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prashant Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.